Skip to main content
. 2013 Feb 17;2013:545631. doi: 10.1155/2013/545631

Figure 2.

Figure 2

Joint analysis of the E1683 and E1690 studies recurrence-free survival/overall survival [33]. Proven benefits in relapse-free survival (HR: 1.30; P 2 = 0.006), but not in overall survival.